CoChat

Cerebral amyloid angiopathy in a 95+ cohort: complement activation and apolipoprotein E (ApoE) genotype

Tanskanen, M., Lindsberg, P. J., Tienari, P. J., Polvikoski, T., Sulkava, R., Verkkoniemi, A., Rastas, S., Paetau, A., Kiuru‐Enari, S. · 2005 · Neuropathology and Applied Neurobiology
Cited by 55

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

Abstract

There is growing evidence that in Alzheimer's disease (AD) amyloid β‐protein (Aβ) triggers a chronic inflammatory reaction in cerebral amyloid plaques, including complement proteins. Aβ also accumulates cerebrovascularly in age‐ and AD‐associated cerebral amyloid angiopathy (CAA). We investigated complement proteins in CAA in a population‐based series using histological and immunohistochemical staining methods. The 74 subjects, aged 95 years or more, had undergone clinical neurological examination and apolipoprotein E (ApoE) genotyping. The brains had been studied for AD post‐mortem, allowing us to relate the histopathological findings to clinical and genetic conditions. CAA with congophilic amyloid was found in 36/74 individuals (48.6%). The vascular amyloid deposits immunoreacted with antibodies to Aβ and complements 3d (C3d) and 9 (C9). The positivity in complement stains increased with growing severity of CAA (P = 0.001). The presence of CAA associated with ApoE ɛ4 (P = 0.0005) and overrepresentation of ɛ4 among those with moderate or severe vs. mild CAA (P = 0.03) was demonstrated. The presence of CAA associated with dementia (P = 0.01), which was contributed by both ɛ4+ (P = 0.02) and ɛ4 – (P = 0.06) subjects. Our study shows that complement proteins are deposited in the affected vessels in Aβ– associated CAA. They may solely represent the cerebral Aβ– burden associated to inflammatory stimuli, or signal a contribution in the clearance of cerebral Aβ, thereby contributing to the events associated with evolution of clinical dementia. Our results demonstrate a strong association between CAA and ApoE ɛ4 as well as dementia and suggest that the contribution of CAA to dementia is largely independent of ApoE ɛ4.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2990.2005.00652.x

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 19 references

Cited by

See all 55

Metadata

Authors
Tanskanen, M., Lindsberg, P. J., Tienari, P. J., Polvikoski, T., Sulkava, R., Verkkoniemi, A., Rastas, S., Paetau, A., & Kiuru‐Enari, S.
Venue
Neuropathology and Applied Neurobiology
Publisher
Wiley
Published
2005-11-09
Volume
31
Issue
6
Pages
589-599
ISSN
  • 0305-1846 (ISSN-L)
  • 1365-2990
OpenAlex
W2064154600
Cited by
55
References
19
FWCI
1.61
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Cerebral amyloid angiopathy in a 95+ cohort: complement activation and apolipoprotein E (ApoE) genotype. https://app.cochat.ai/papers/10.1111/j.1365-2990.2005.00652.x
The paper
Tanskanen, M., Lindsberg, P. J., Tienari, P. J., Polvikoski, T., Sulkava, R., Verkkoniemi, A., Rastas, S., Paetau, A., & Kiuru‐Enari, S. (2005). Cerebral amyloid angiopathy in a 95+ cohort: complement activation and apolipoprotein E (ApoE) genotype. Neuropathology and Applied Neurobiology. https://doi.org/10.1111/j.1365-2990.2005.00652.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.